Skip to content
OpenCapital
Get started

AIM ImmunoTech AIM Q4 2024 Annual earnings

Reported March 27, 2025 · Before market open

Revenue$45.0KMiss by $55.0KDiluted EPS-$10.00Miss by $1.00
Revenue estimate$100.0K
EPS estimate-$9.00

Next report

Aug 13, 2026 (in a month)
Revenue estimate$100.0K
EPS estimate-$0.17

Versus estimates

Revenue

Q1 2026$22.0KBeat by $11.0KQ4 2025$21.0KMiss by $79.0KQ3 2025$26.0KQ2 2025$25.0KMiss by $75.0KQ1 2025$16.0K
Q4 2024$45.0KMiss by $55.0K

Diluted EPS

Q1 2026-$0.69Beat by $0.39Q4 2025-$0.44Beat by $0.50Q3 2025-$1.57Miss by $0.59Q2 2025-$3.68Beat by $4.32Q1 2025-$5.00Beat by $3.00
Q4 2024-$10.00Miss by $1.00

Ask the moment AIM ImmunoTech reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did AIM ImmunoTech report Q4 2024 earnings?
AIM ImmunoTech (AIM) reported Q4 2024 earnings on March 27, 2025 before market open.
What were AIM ImmunoTech's Q4 2024 revenue and EPS?
AIM ImmunoTech reported revenue of $45.0K and diluted EPS of $-10.00 for Q4 2024.
Did AIM ImmunoTech beat estimates in Q4 2024?
Revenue missed the consensus estimate of $100.0K by $55.0K. EPS missed the consensus estimate of $-9.00 by $1.00.
Where can I find AIM ImmunoTech's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-000847) directly on SEC EDGAR. The filing index links above go to sec.gov.